The 10-second takeaway
For the quarter ended June 30 (Q2), Tenet Healthcare met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share dropped to a loss.
Gross margins improved, operating margins grew, net margins contracted.
Tenet Healthcare logged revenue of $2.46 billion. The 12 analysts polled by S&P Capital IQ foresaw sales of $2.45 billion on the same basis. GAAP reported sales were 3.4% higher than the prior-year quarter's $2.37 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.10. The 15 earnings estimates compiled by S&P Capital IQ anticipated $0.05 per share. GAAP EPS were -$0.19 for Q2 against $0.11 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 41.2%, 10 basis points better than the prior-year quarter. Operating margin was 7.5%, 20 basis points better than the prior-year quarter. Net margin was -0.1%, 270 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $2.45 billion. On the bottom line, the average EPS estimate is $0.09.
Next year's average estimate for revenue is $9.99 billion. The average EPS estimate is $0.53.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 360 members rating the stock outperform and 70 members rating it underperform. Among 76 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 59 give Tenet Healthcare a green thumbs-up, and 17 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Tenet Healthcare is hold, with an average price target of $5.98.
- Add Tenet Healthcare to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.